Browse Category

NYSE:AZN News 20 January 2026

AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates

New York, January 20, 2026, 11:21 EST — Regular session AstraZeneca PLC’s U.S.-listed shares fell Tuesday after the company revealed plans to pull its American depositary shares from Nasdaq and directly list ordinary shares on the New York Stock Exchange. The stock slid 4.4%, dropping to $90.23 in late morning trading. The switch swaps depositary-share wrappers for ordinary shares in…

Stock Market Today

  • SLB Shares Show Strong Momentum Amid 46% Discount to Intrinsic Value
    January 22, 2026, 6:18 AM EST. SLB (NYSE:SLB) surged recently, posting a 26.58% gain in one month and 34.74% over three months, attracting investor attention. Despite a 7.01% decline over three years, the stock offers a compelling valuation based on its price-to-earnings (P/E) ratio of 19.9x, below the US energy services sector average of 22.2x. The firm recorded revenue of $35.247 billion and net income of $3.645 billion. Simply Wall St's discounted cash flow (DCF) model estimates SLB's intrinsic value at $90.62, implying shares trade at a 46% discount. The gap suggests the market may be factoring in risks or lower growth expectations. Investors should weigh recent momentum against these valuation metrics and risks in the energy services sector.
Go toTop